Chantal Chavoix
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Chantal Chavoix has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Rémy Morello
Department of Statistics and Clinical Research, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, 14000, France
3 shared publicationsAlice Pellichero
Centre for Interdisciplinary Research in Rehabilitation and Social Integration (Cirris), Centre Intégré Universitaire de Santé et de Services Sociaux de la Capitale-Nationale (CIUSSS-CN), Quebec City, QC, G1M 2S8, Canada
2 shared publicationsChristian Marcelli
Normandie Univ, UNICAEN, INSERM, COMETE, Caen, France
2 shared publicationsColette Fabrigoule
USR 3413 CNRS/Université Bordeaux Segalen, CHU Pellegrin, F-33076 Bordeaux, France
2 shared publicationsElpidio Attoh-Mensah
Normandie Univ, UNICAEN, INSERM, COMETE, Caen, France
2 shared publicationsGilles Loggia
Normandie Univ, UNICAEN, INSERM, COMETE, Caen, France
2 shared publications
Latest Publications
- 14 August 2023
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 78 (12) , 2458-2465
Gripwise Versus Jamar: The Challenge of a New Dynamometer Assessing Handgrip Strength
Background: Sarcopenia diagnosis is partly based on handgrip strength (HGS) assessment. The gold-standard dynamometer for this measurement is the Jamar. The electronic Gripwise is a smaller and lighter one, and its measurements are correlated with the Jamar’s in laboratory tests. Our study aimed to confirm this correlation in aged patients. Methods: This monocenter cross-sectional study was performed in patients of 65 years and older admitted at the University Hospital. Participants were assessed either in a seated or bedridden position, randomly allocated to begin the measurements with the Jamar or the Gripwise. Results: Among 649 aged inpatients assessed for eligibility, 348 were included (mean age: 79 ± 9; 52% females). The intraclass correlation coefficient was 0.93 (95% confidence interval [CI] 0.92–0.94, p < .001) for the maximum value measured with both devices and 0.94 (95% CI 0.93–0.95, p < .001) for the mean values. However, there was a significant difference in detecting low values (<16 kg in women, <27 kg in men), found in 48% of patients with Jamar, and 71% with Gripwise (p < .001). Thus, we determined alternate cutoffs for diagnosing HGS low values with the Gripwise (<12 kg in women, <22 kg in men), further validated in a supplementary validation population (n = 70). The diagnostic performances of these alternative cutoffs were high (93% sensitivity and 87% specificity in women; 94% sensitivity and 96% specificity in men). Conclusions: The correlation of the Gripwise with the Jamar was confirmed in aged inpatients. However, lower values recorded with the Gripwise require alternate cutoffs for a relevant low HGS diagnosis.
- 14 August 2023
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 78 (12) , 2458-2465
Gripwise Versus Jamar: The Challenge of a New Dynamometer Assessing Handgrip Strength
Background: Sarcopenia diagnosis is partly based on handgrip strength (HGS) assessment. The gold-standard dynamometer for this measurement is the Jamar. The electronic Gripwise is a smaller and lighter one, and its measurements are correlated with the Jamar’s in laboratory tests. Our study aimed to confirm this correlation in aged patients. Methods: This monocenter cross-sectional study was performed in patients of 65 years and older admitted at the University Hospital. Participants were assessed either in a seated or bedridden position, randomly allocated to begin the measurements with the Jamar or the Gripwise. Results: Among 649 aged inpatients assessed for eligibility, 348 were included (mean age: 79 ± 9; 52% females). The intraclass correlation coefficient was 0.93 (95% confidence interval [CI] 0.92–0.94, p < .001) for the maximum value measured with both devices and 0.94 (95% CI 0.93–0.95, p < .001) for the mean values. However, there was a significant difference in detecting low values (<16 kg in women, <27 kg in men), found in 48% of patients with Jamar, and 71% with Gripwise (p < .001). Thus, we determined alternate cutoffs for diagnosing HGS low values with the Gripwise (<12 kg in women, <22 kg in men), further validated in a supplementary validation population (n = 70). The diagnostic performances of these alternative cutoffs were high (93% sensitivity and 87% specificity in women; 94% sensitivity and 96% specificity in men). Conclusions: The correlation of the Gripwise with the Jamar was confirmed in aged inpatients. However, lower values recorded with the Gripwise require alternate cutoffs for a relevant low HGS diagnosis.
- Open Access
- 1 March 2023
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 18, 327-341
The PAPA Questionnaire: Assessment of Long-Term Engagement in Activities, with Separate Quantification of Their Physical, Cognitive, and Social Components
Purpose: Engagement in activities promotes healthy living. Evaluating it is a challenging issue. Assessing engagement in activities while differentiating the physical, cognitive, and social component of each activity and taking into account the intensity level involved in each of the three components would be very relevant. Since none of the currently available cognitive reserve and questionnaires on the activities practiced takes into consideration both points, the purpose of this new questionnaire, called Pertinent Activities Practice in Adults (PAPA) questionnaire, is to fill these gaps. Patients and Methods: The questionnaire was developed through a literature review and interviews with older adults (n=177 ≥ 55 years). The intensity level of each item (none, light, moderate, or high) was determined by the compendium of physical activities for the physical component and consensus for the cognitive and social components, then validated by 56 professional experts (6 groups: physiotherapists, neuropsychologists, occupational therapists, geriatricians, etc.). Results: The PAPA questionnaire includes 75 items that give rise to 4 scores (sedentary lifestyle and physical, cognitive, and social activity scores) weighted by the frequency, duration, and intensity level for each component. The weighted percentage of agreement of the expert groups for the intensity levels was never significantly lower than the minimum target threshold (80% of the hypothetical median) except in a single domain (cognitive) for an expert group non-specialized in cognition. Cronbach’s alpha was ≥ 0.85. Conclusion: This questionnaire, which assesses long-term engagement in activities, with separate quantification of the physical, cognitive, and social components of a wide range of activities, should help guide actions to promote healthy aging and reduce dementia risk.
- 1 March 2023
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 18, 327-341
Open AccessThe PAPA Questionnaire: Assessment of Long-Term Engagement in Activities, with Separate Quantification of Their Physical, Cognitive, and Social Components
Purpose: Engagement in activities promotes healthy living. Evaluating it is a challenging issue. Assessing engagement in activities while differentiating the physical, cognitive, and social component of each activity and taking into account the intensity level involved in each of the three components would be very relevant. Since none of the currently available cognitive reserve and questionnaires on the activities practiced takes into consideration both points, the purpose of this new questionnaire, called Pertinent Activities Practice in Adults (PAPA) questionnaire, is to fill these gaps. Patients and Methods: The questionnaire was developed through a literature review and interviews with older adults (n=177 ≥ 55 years). The intensity level of each item (none, light, moderate, or high) was determined by the compendium of physical activities for the physical component and consensus for the cognitive and social components, then validated by 56 professional experts (6 groups: physiotherapists, neuropsychologists, occupational therapists, geriatricians, etc.). Results: The PAPA questionnaire includes 75 items that give rise to 4 scores (sedentary lifestyle and physical, cognitive, and social activity scores) weighted by the frequency, duration, and intensity level for each component. The weighted percentage of agreement of the expert groups for the intensity levels was never significantly lower than the minimum target threshold (80% of the hypothetical median) except in a single domain (cognitive) for an expert group non-specialized in cognition. Cronbach’s alpha was ≥ 0.85. Conclusion: This questionnaire, which assesses long-term engagement in activities, with separate quantification of the physical, cognitive, and social components of a wide range of activities, should help guide actions to promote healthy aging and reduce dementia risk.
- 1 March 2021
- Published by Elsevier in Annals of Physical and Rehabilitation Medicine
- Vol. 64 (2) , 101373
Barriers and facilitators to social participation after driving cessation among older adults: A cohort study
- 1 March 2021
- Published by Elsevier in Annals of Physical and Rehabilitation Medicine
- Vol. 64 (2) , 101373
Barriers and facilitators to social participation after driving cessation among older adults: A cohort study
- 14 December 2020
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences
- Vol. 76 (6) , 1077-1085
Relationships Between Cognitive and Driving Self-awareness in Older Drivers
Objectives: Many older drivers incorrectly estimate their driving ability. The present study aimed to determine whether, and if so, to what extent unawareness of cognitive abilities affects self-awareness of driving ability. Method: Two successive studies were conducted in older drivers. A cohort study investigated cognitive self-awareness and an experimental study examined driving self-awareness. In each one, self-awareness was assessed by cross-analyzing objective (respectively Trail-Making Tests A and B and the Digit Symbol Substitution Test and driving performance of on-road assessment) and subjective data (responses about everyday cognitive skills and driving ability). Older drivers were then classified as being over-, correct, or underestimators. The 3 cognitive and driving self-awareness profiles were then cross-analyzed. Results: In the cohort study, 1,190 drivers aged 70 years or older were included. The results showed that 42.7% of older drivers overestimated their cognitive ability, 42.2% estimated it correctly, and 15.1% underestimated it. The experimental study included 145 participants from the cohort. The results showed that 34% of participants overestimated, 45% correctly estimated, and 21% underestimated their driving ability. There was a significant relationship between cognitive and driving self-awareness profiles (p = .02). This overlap was more marked in overestimators. Discussion: Significant overlap between cognitive and driving self-awareness provides useful and new knowledge about driving in the aging population. Misestimation of cognitive ability could hamper self-awareness of driving ability, and consequently self-regulation of driving. It is now crucial to develop measures that promote self-awareness of ability.
- 14 December 2020
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences
- Vol. 76 (6) , 1077-1085
Relationships Between Cognitive and Driving Self-awareness in Older Drivers
Objectives: Many older drivers incorrectly estimate their driving ability. The present study aimed to determine whether, and if so, to what extent unawareness of cognitive abilities affects self-awareness of driving ability. Method: Two successive studies were conducted in older drivers. A cohort study investigated cognitive self-awareness and an experimental study examined driving self-awareness. In each one, self-awareness was assessed by cross-analyzing objective (respectively Trail-Making Tests A and B and the Digit Symbol Substitution Test and driving performance of on-road assessment) and subjective data (responses about everyday cognitive skills and driving ability). Older drivers were then classified as being over-, correct, or underestimators. The 3 cognitive and driving self-awareness profiles were then cross-analyzed. Results: In the cohort study, 1,190 drivers aged 70 years or older were included. The results showed that 42.7% of older drivers overestimated their cognitive ability, 42.2% estimated it correctly, and 15.1% underestimated it. The experimental study included 145 participants from the cohort. The results showed that 34% of participants overestimated, 45% correctly estimated, and 21% underestimated their driving ability. There was a significant relationship between cognitive and driving self-awareness profiles (p = .02). This overlap was more marked in overestimators. Discussion: Significant overlap between cognitive and driving self-awareness provides useful and new knowledge about driving in the aging population. Misestimation of cognitive ability could hamper self-awareness of driving ability, and consequently self-regulation of driving. It is now crucial to develop measures that promote self-awareness of ability.
- Open Access
- 30 January 2020
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 10, 1659
Psychotropic Polypharmacy in Adults 55 Years or Older: A Risk for Impaired Global Cognition, Executive Function, and Mobility
Objectives: With their broad spectrum of action, psychotropic drugs are among the most common medications prescribed to the elderly. Consequently, the number of older adults taking multiple psychotropic drugs has more than doubled over the last decade. To improve knowledge about the deleterious effects of psychotropic polypharmacy, we investigated whether there is a threshold number of psychotropic molecules that could lead to impairment of global cognition, executive function, or mobility. Furthermore, relationships between the number of psychotropic molecules and cognitive and mobility impairment were examined. Design: Cross-sectional study Setting: University Hospital of Caen (France) and advertisements in medical offices Participants: Community-dwelling older adults 55 years and older (n = 177; 69.8 ± 9.3 years; 81% women) Measurements: Number of psychotropic molecules taken daily, global cognition assessed with the Mini Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA), processing speed with the Trail Making Test (TMT) A, executive function with the TMT B and TMT B-A, and mobility with the Time Up and Go (TUG). The threshold numbers of psychotropic molecules were determined by ROC curves analysis. Based on these threshold values, multinomial logistic regression adjusting for covariates was then performed. Results: Logistic regressions showed that the threshold of two daily psychotropic molecules, identified by the ROC curves analysis, increases the risk of impaired executive function (p = .05 and.005 for the TMT B and TMT B-A, respectively), global cognition (p = .006 and.001 for the MMSE and MoCA, respectively), and mobility (p = .005 for the TUG), independent of confounding factors, including comorbidities. Furthermore, psychotropic polypharmacy would affect mobility through executive functions. Conclusion: Impairment of global cognition, executive function, and mobility when as few as two psychotropic molecules are consumed in relatively healthy young older adults should alert physicians when prescribing combinations of psychotropic medications.
- 30 January 2020
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 10, 1659
Open AccessPsychotropic Polypharmacy in Adults 55 Years or Older: A Risk for Impaired Global Cognition, Executive Function, and Mobility
Objectives: With their broad spectrum of action, psychotropic drugs are among the most common medications prescribed to the elderly. Consequently, the number of older adults taking multiple psychotropic drugs has more than doubled over the last decade. To improve knowledge about the deleterious effects of psychotropic polypharmacy, we investigated whether there is a threshold number of psychotropic molecules that could lead to impairment of global cognition, executive function, or mobility. Furthermore, relationships between the number of psychotropic molecules and cognitive and mobility impairment were examined. Design: Cross-sectional study Setting: University Hospital of Caen (France) and advertisements in medical offices Participants: Community-dwelling older adults 55 years and older (n = 177; 69.8 ± 9.3 years; 81% women) Measurements: Number of psychotropic molecules taken daily, global cognition assessed with the Mini Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA), processing speed with the Trail Making Test (TMT) A, executive function with the TMT B and TMT B-A, and mobility with the Time Up and Go (TUG). The threshold numbers of psychotropic molecules were determined by ROC curves analysis. Based on these threshold values, multinomial logistic regression adjusting for covariates was then performed. Results: Logistic regressions showed that the threshold of two daily psychotropic molecules, identified by the ROC curves analysis, increases the risk of impaired executive function (p = .05 and.005 for the TMT B and TMT B-A, respectively), global cognition (p = .006 and.001 for the MMSE and MoCA, respectively), and mobility (p = .005 for the TUG), independent of confounding factors, including comorbidities. Furthermore, psychotropic polypharmacy would affect mobility through executive functions. Conclusion: Impairment of global cognition, executive function, and mobility when as few as two psychotropic molecules are consumed in relatively healthy young older adults should alert physicians when prescribing combinations of psychotropic medications.
- 13 January 2020
- Published by Springer Nature in Drugs & Aging
- Vol. 37 (4) , 301-310
Adverse Effects of Anticholinergic Drugs on Cognition and Mobility: Cutoff for Impairment in a Cross-Sectional Study in Young–Old and Old–Old Adults
Background Drugs with anticholinergic properties are commonly prescribed in older adults despite growing evidence of their adverse outcomes. Several issues regarding these detrimental effects remain unresolved, such as the putative existence of a threshold above which anticholinergic drug consumption impairs cognitive or mobility performance. Objectives We aimed to investigate the number of anticholinergic drugs and the anticholinergic burden that leads to mobility or cognitive impairment and compare the effects in community-dwelling older adults in two age groups (“young–old” 55–74 vs. “old–old” ≥ 75 years). Methods In a cross-sectional study, we identified drugs with anticholinergic (antimuscarinic) properties using the Anticholinergic Drug Scale. Cognition was assessed using the Mini Mental State Examination (MMSE) and the Trail Making Test (TMT-A and TMT-B), and mobility was assessed using the Timed Up and Go (TUG) test. Results The study population consisted of 177 volunteers, 114 of whom were classed as young–old and 63 were classed as old–old adults. Despite the lack of cutoff values for impaired outcomes in young-old adults, impaired MMSE were significantly more numerous in users than in nonusers of anticholinergic drugs. In old–old adults, receiver operating characteristic (ROC) curve analysis indicated that taking a single anticholinergic drug per day was associated with impaired TMT-B completion time, TMT difference score (B–A), and TUG scores. The cutoff for anticholinergic burden was also one for these same outcomes. Based on these cutoff values, multivariate logistic regressions in old–old adults showed that the increased risk of impaired cognition and mobility was independent of confounding factors, including comorbidities. They also suggested that anticholinergic drugs would affect mobility through executive functions. Conclusions Drugs with anticholinergic (antimuscarinic) properties are associated with cognitive impairment in individuals as young as 55 years, and only one such drug per day, regardless of its anticholinergic burden, is associated with both impaired cognition and impaired mobility in old–old adults. Therefore, wherever possible, clinicians should avoid prescribing drugs with anticholinergic properties.
- 13 January 2020
- Published by Springer Nature in Drugs & Aging
- Vol. 37 (4) , 301-310
Adverse Effects of Anticholinergic Drugs on Cognition and Mobility: Cutoff for Impairment in a Cross-Sectional Study in Young–Old and Old–Old Adults
Background Drugs with anticholinergic properties are commonly prescribed in older adults despite growing evidence of their adverse outcomes. Several issues regarding these detrimental effects remain unresolved, such as the putative existence of a threshold above which anticholinergic drug consumption impairs cognitive or mobility performance. Objectives We aimed to investigate the number of anticholinergic drugs and the anticholinergic burden that leads to mobility or cognitive impairment and compare the effects in community-dwelling older adults in two age groups (“young–old” 55–74 vs. “old–old” ≥ 75 years). Methods In a cross-sectional study, we identified drugs with anticholinergic (antimuscarinic) properties using the Anticholinergic Drug Scale. Cognition was assessed using the Mini Mental State Examination (MMSE) and the Trail Making Test (TMT-A and TMT-B), and mobility was assessed using the Timed Up and Go (TUG) test. Results The study population consisted of 177 volunteers, 114 of whom were classed as young–old and 63 were classed as old–old adults. Despite the lack of cutoff values for impaired outcomes in young-old adults, impaired MMSE were significantly more numerous in users than in nonusers of anticholinergic drugs. In old–old adults, receiver operating characteristic (ROC) curve analysis indicated that taking a single anticholinergic drug per day was associated with impaired TMT-B completion time, TMT difference score (B–A), and TUG scores. The cutoff for anticholinergic burden was also one for these same outcomes. Based on these cutoff values, multivariate logistic regressions in old–old adults showed that the increased risk of impaired cognition and mobility was independent of confounding factors, including comorbidities. They also suggested that anticholinergic drugs would affect mobility through executive functions. Conclusions Drugs with anticholinergic (antimuscarinic) properties are associated with cognitive impairment in individuals as young as 55 years, and only one such drug per day, regardless of its anticholinergic burden, is associated with both impaired cognition and impaired mobility in old–old adults. Therefore, wherever possible, clinicians should avoid prescribing drugs with anticholinergic properties.
- 29 January 2019
- Published by Association Nationale Française des Ergothérapeutes in ErgOThérapies
- Vol. 72, 61-66
Réglementation encadrant les recherches en ergothérapie en France : la loi Jardé et son évolution
Note de la rédaction : Nous reproduisons cet article avec l’aimable autorisation de la publication « Le Monde de l’ergothérapie », éditée par l’ANFE. Cet article est paru en décembre 2018 dans Le Monde de l’ergothérapie n° 40, pages 14 à 17. De grands changements concernant la réglementation de la recherche en France impliquant la personne humaine sont…
- 29 January 2019
- Published by Association Nationale Française des Ergothérapeutes in ErgOThérapies
- Vol. 72, 61-66
Réglementation encadrant les recherches en ergothérapie en France : la loi Jardé et son évolution
Note de la rédaction : Nous reproduisons cet article avec l’aimable autorisation de la publication « Le Monde de l’ergothérapie », éditée par l’ANFE. Cet article est paru en décembre 2018 dans Le Monde de l’ergothérapie n° 40, pages 14 à 17. De grands changements concernant la réglementation de la recherche en France impliquant la personne humaine sont…
- 1 July 2017
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 78, 1-12
Self-awareness and the medial temporal lobe in neurodegenerative diseases
- 1 July 2017
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 78, 1-12
Self-awareness and the medial temporal lobe in neurodegenerative diseases
- 30 August 2007
- Published by Wiley in Journal of Neuroimaging
- Vol. 17 (4) , 277-285
Functional Imaging of Working Memory in Parkinson's Disease: Compensations and Deficits
BACKGROUND AND PURPOSE: Over and above typical motor alterations, executive and working memory (WM) impairment can also occur in early idiopathic Parkinson's disease (PD). We aimed to investigate the compensatory neural processes involved in WM performance, as well as the networks involved in the long‐term memory transfer from short‐term stores in PD. METHODS: Relative cerebral blood flow (rCBF) was mapped with H2O15‐PET in eight treated nondemented PD patients while performing a WM verbal double‐task (Brown‐Peterson paradigm) using both short (6‐second) and long (18‐second) delays. RESULTS: As compared to nine age‐matched healthy subjects, performance of the PD group was only slightly reduced on the short‐delay but markedly impaired on the long‐delay task. Underlying the relatively preserved short‐delay performance, the PD group exhibited overactivation of prefrontal and parietal areas involved in attention‐demanding processes, suggestive of efficient compensatory processes. Further supporting this, significant positive correlations were found between short‐delay performance and rCBF in the bilateral inferior parietal cortex. In contrast, the lack of overactivation with the long‐delay task together with posterior cingulate hypoactivation would support the idea of functional disconnection impairing transfer of information from prefrontal onto (para)limbic areas. These findings suggest novel areas of investigation into early cognitive impairments in PD.
- 30 August 2007
- Published by Wiley in Journal of Neuroimaging
- Vol. 17 (4) , 277-285
Functional Imaging of Working Memory in Parkinson's Disease: Compensations and Deficits
BACKGROUND AND PURPOSE: Over and above typical motor alterations, executive and working memory (WM) impairment can also occur in early idiopathic Parkinson's disease (PD). We aimed to investigate the compensatory neural processes involved in WM performance, as well as the networks involved in the long‐term memory transfer from short‐term stores in PD. METHODS: Relative cerebral blood flow (rCBF) was mapped with H2O15‐PET in eight treated nondemented PD patients while performing a WM verbal double‐task (Brown‐Peterson paradigm) using both short (6‐second) and long (18‐second) delays. RESULTS: As compared to nine age‐matched healthy subjects, performance of the PD group was only slightly reduced on the short‐delay but markedly impaired on the long‐delay task. Underlying the relatively preserved short‐delay performance, the PD group exhibited overactivation of prefrontal and parietal areas involved in attention‐demanding processes, suggestive of efficient compensatory processes. Further supporting this, significant positive correlations were found between short‐delay performance and rCBF in the bilateral inferior parietal cortex. In contrast, the lack of overactivation with the long‐delay task together with posterior cingulate hypoactivation would support the idea of functional disconnection impairing transfer of information from prefrontal onto (para)limbic areas. These findings suggest novel areas of investigation into early cognitive impairments in PD.